Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Suzhou Novoprotein Scientific Co., Ltd. has issued an announcement regarding abnormal fluctuations in its stock trading, noting significant price increases over several trading days. The company confirmed that there are no undisclosed significant matters affecting its stock price and that its production activities are normal. The board of directors has assured that all necessary disclosures have been made and warned investors about potential trading risks due to recent stock price increases.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/novoprotein-scientific-incannouncement-on-abnormal-fluctuations-in-stock-trading
Suzhou Novoprotein Scientific Co., Ltd. on 6ix
Earlier from Suzhou Novoprotein Scientific
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Reply to the Regulatory Inquiry Letter from SSE on Information Disclosure of the 2025 Annual Report
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Remuneration Plan for Directors and Senior Management Members in 2026
Later from Suzhou Novoprotein Scientific
- Announcement on Abnormal Fluctuations in Stock Trading and Risk Warning of Expected Loss
- Announcement on Severe Abnormal Fluctuations in Stock Trading
- Announcement on Extension of Certain Raised Funds Investment Projects
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- (688137)"NOVOPROTEIN SCIENTIFIC INC."Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Suzhou Novoprotein Scientific into a list and get an email when it puts out news.
Follow Suzhou Novoprotein Scientific